1 |
S. Furukawa et al. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation, 114(12), 1752-1761. DOI : 10.1172/JCI21625
DOI
|
2 |
J. Fang & M. H. Alderman. (2000). Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. Journal of the American Medical Association, 283(18), 2404-2410. DOI : 10.1001/jama.283.18.2404
DOI
|
3 |
M. J. Bos, P. J. Koudstaal, A. Hofman, J. C. M. Witteman & M. M. B. Breteler. (2006). Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke, 37(6), 1503-1507. DOI : 10.1161/01.STR.0000221716.55088.d4
DOI
|
4 |
K. Nagahama, K. Iseki, T. Inoue, T. Touma, Y. Ikemiya & S. Takishita. (2004). Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertension Research, 27(4), 227-233. DOI : 10.1291/hypres.27.227
DOI
|
5 |
S. Ohno et al. (2018). Recovery of Endothelial Function after Minor-to-Moderate Surgery Is Impaired by Diabetes Mellitus, Obesity, Hyperuricemia and Sevoflurane-Based Anesthesia. International Heart Journal, 59(3), 559-565. DOI : 10.1536/ihj.17-143
DOI
|
6 |
Z. Soltani, K. Rasheed, D. R. Kapusta & E. Reisin. (2013). Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Current Hypertension Reports, 15(3), 175-181. DOI : 10.1007/s11906-013-0344-5
DOI
|
7 |
A. Costa, I. Iguala, J. Bedini, L. Quinto & I. Conget. (2002). Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism, 51(3), 372-375. DOI : 10.1053/meta.2002.30523
DOI
|
8 |
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). The Journal of the American Medical Association, 285(19), 2486-2497. DOI : 10.1001/jama.285.19.2486
DOI
|
9 |
World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia.
|
10 |
H. Choi et al. (2016). Serum uric acid concentration and metabolic syndrome among elderly Koreans: The Korean Urban Rural Elderly (KURE) study. Archives of Gerontology and Geriatrics, 64, 51-58. DOI : 10.1016/j.archger.2016.01.005
DOI
|
11 |
L. B. Salaroli, M. Cattafesta, M. D. C. B. Molina, E. Zandonade & N. S. Bissoli. (2017). Insulin resistance and associated factors: a cross-sectional study of bank employees. Clinics (Sao Paulo, Brazil), 72(4), 224-230. DOI : 10.6061/clinics/2017(04)06
DOI
|
12 |
S. O. V. Nunes et al. (2014). Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence. Psychiatric Genetics, 24(3), 87-93. DOI : 10.1097/YPG.0000000000000023
DOI
|
13 |
A. M. Johnson & J. M. Olefsky. (2013). The origins and drivers of insulin resistance. Cell, 152(4), 673-684. DOI : 10.1016/j.cell.2013.01.041
DOI
|
14 |
B. Isomaa et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4), 683-689. DOI : 10.2337/diacare.24.4.683
DOI
|
15 |
Y. He et al. (2006). Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. Journal of the American College of Cardiology, 47(8), 1588-1594. DOI : 10.1016/j.jacc.2005.11.074
DOI
|
16 |
N. Ali et al. (2020). Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Scientific Reports, 10(1), 7841. DOI : 10.1038/s41598-020-64884-7
DOI
|
17 |
H. Sumiyoshi, Y. Ohyama, K. Imai, M. Kurabayashi, Y. Saito & T. Nakamura. (2019). Association of uric acid with incident metabolic syndrome in a Japanese general population. International Heart Journal, 60(4), 830-835. DOI : 10.1536/ihj.18-444
DOI
|
18 |
M. H. Kim et al. (2020). The change of metabolic syndrome prevalence and its risk factors in Korean adults for decade: Korea National Health and Nutrition Examination Survey for 2008-2017. Korean Journal of Family Practice, 10(2), 44-52. DOI : 10.21215/kjfp.2020.10.1.44
DOI
|
19 |
A. Onat et al. (2006). Serum uric acid is a determinant of metabolic syndrome in a population-based study. American Journal of Hypertension, 19(10), 1055-1062. DOI : 10.1016/j.amjhyper.2006.02.014
DOI
|
20 |
R. L. Borges, A. B. Ribeiro, M. T. Zanella & M. C. Batista. (2010). Uric acid as a factor in the metabolic syndrome. Current Hypertension Reports, 12(2), 113-119. DOI : 10.1007/s11906-010-0098-2
DOI
|
21 |
A. Galassi, K. Reynolds & J. He. (2006). Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine, 119(10), 812-819. DOI : 10.1016/j.amjmed.2006.02.031
DOI
|
22 |
E. S. Ford, M. B. Schulze, T. Pischon, M. M. Bergmann, H. G. Joost & H. Boeing. (2008). Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Cardiovascular Diabetology, 12(7), 35. DOI : 10.1186/1475-2840-7-35
DOI
|
23 |
L'. Cibickova, K. Langova, H. Vaverkova, V. Kubickova & D. Karasek. (2017). Correlation of uric acid levels and parameters of metabolic syndrome. Physiological Research, 66(3), 481-487. DOI : 10.33549/physiolres.933410
DOI
|
24 |
K. A. Shin. (2017). Clinical usefulness of serum uric acid and resting heart rate in the diagnosis of metabolic syndrome in Korean adults. Biomedical Science Letters, 23(2), 118-127.
DOI
|
25 |
S. P. Hong et al. (2008). Relationship between serum uric acid level and metabolic syndrome according to gender. Korean Circulation Journal, 38(3), 152-160. DOI : 10.4070/kcj.2008.38.3.152
DOI
|
26 |
E. Adnan, I. A. Rahman & H. P. Faridin. (2019). Relationship between insulin resistance, metabolic syndrome components and serum uric acid. Diabetes & Metabolic Syndrome, 13(3), 2158-2162. DOI : 10.1016/j.dsx.2019.04.001
DOI
|
27 |
D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher & R. C. Turner. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. DOI : 10.1007/BF00280883
DOI
|
28 |
S. Lee et al. (2006). Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. Journal of Korean Medical Science, 21(4), 695-700. DOI : 10.3346/jkms.2006.21.4.695
DOI
|
29 |
C. F. Kuo, L. C. See, K. H. Yu, I. J. Chou, M. J. Chiou & S. F. Luo. (2013). Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford), 52(1), 127-134. DOI : 10.1093/rheumatology/kes223
DOI
|
30 |
Y. Q. Fu et al. (2017). Positive association between metabolic syndrome and serum uric acid in Wuhan. Asia Pacific Journal of Clinical Nutrition, 26(2), 343-350. DOI : 10.6133/apjcn.012016.06
DOI
|
31 |
S. Ciarla et al. (2014). Serum uric acid levels and metabolic syndrome. Archives of Physiology and Biochemistry, 120(3), 119-122. DOI : 10.3109/13813455.2014.924145
DOI
|
32 |
B. Liu et al. (2011). The prevalence of hyperuricemia in China: a meta-analysis. BioMed Central Public Health, 27(11), 832. DOI : 10.1186/1471-2458-11-832
DOI
|
33 |
K. Esposito, P. Chiodini, A. Colao, A. Lenzi & D. Giugliano. (2012). Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care, 35(11), 2402-2411. DOI : 10.2337/dc12-0336
DOI
|
34 |
J. Zhou et al. (2013). Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone, 57(1), 30-35. DOI : 10.1016/j.bone.2013.07.013
DOI
|
35 |
T. W. Yoo et al. (2005). Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circulation Journal, 69(8), 928-933. DOI : 10.1253/circj.69.928
DOI
|
36 |
E. S. Ford, C. Li, S. Cook & H. K. Choi. (2007). Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation, 15(19), 2526-2532. DOI : 10.1161/CIRCULATIONAHA.106.657627
DOI
|
37 |
V. Guarner & M. E. Rubio-Ruiz. (2015). Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdisciplinary Topics in Gerontology, 40, 99-106. DOI : 10.1159/000364934
DOI
|
38 |
G. Mercuro et al. (2004). Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. American Journal of Cardiology, 94(7), 932-935. DOI : 10.1016/j.amjcard.2004.06.032
DOI
|
39 |
M. Abbasian, H. Ebrahimi, M. Delvarianzadeh, P. Norouzi & M. Fazli. (2016). Association between serum uric acid (SUA) levels and metabolic syndrome (MetS) components in personnel of Shahroud University of Medical Sciences. Diabetology & Metabolic Syndrome, 10(3), 132-136. DOI : 10.1016/j.dsx.2016.01.003
DOI
|
40 |
Z. Zhang, L. Bian & Y. Choi. (2012). Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. Angiology, 63(6), 420-428. DOI : 10.1177/0003319711423806
DOI
|
41 |
G. Wu & C. J. Meininger. (2009). Nitric oxide and vascular insulin resistance. Biofactors, 35(1), 21-27. DOI : 10.1002/biof.3
DOI
|
42 |
R. Meshkani, M. Zargari & B. Larijani. (2011). The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetologica, 48(1), 79-88. DOI : 10.1007/s00592-010-0231-3
DOI
|